Daiichi Sankyo (United States)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
50%
Total
Publications
1.5K
Total Open
Publications
770
Total
Citations
50K
Open Access
Percentage
50%
Total
Publications
1.5K
Total Open
Publications
770
Total
Citations
50K
Breakdown
Publisher Open
26%
Both
20%
Other Platform Open
4%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
196
Hybrid 46%
325
No Guarantees 26%
181
Other Platform Open
Domain 81%
300
Institution 25%
93
Other Internet 15%
56
Public 2%
8
Preprint 1%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 302 |
DOI | Other Internet | 38 |
DANS - Data Archiving and Networked Services | Institution | 36 |
Unknown Repository | Other Internet | 19 |
universiteitleiden.nl OAI-PMH Repository | Institution | 13 |
Europe PMC | Domain | 10 |
DASH - Digital Access to Scholarship at Harvard | Institution | 8 |
Yonsei University Medical Library - YUHSpace | Institution | 7 |
Figshare | Public | 7 |
Elsevier - Scopus | Institution | 7 |